Viewing Study NCT07213804

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-03-08 @ 4:27 AM
Study NCT ID: NCT07213804
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2025-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Neoplasms View
None Fallopian Tube Neoplasms View
None Peritoneal Neoplasms View
None Neoplasm Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Folate Receptor Alpha View
None Antibody-drug Conjugate View
None Platinum-Resistant View
None Platinum-Sensitive View
None sofe-m View